Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease
Condition(s):Cerebral Small Vessel DiseasesLast Updated:November 2, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Cerebral Small Vessel DiseasesLast Updated:November 2, 2020Unknown status
Condition(s):Alzheimer’s Disease; Mild Cognitive Impairment; HealthyLast Updated:October 25, 2007Unknown status
Condition(s):Mild Cognitive Impairment; Alzheimer Disease; Dementia, Vascular; Dementia With Lewy Bodies; Dementia Frontal; Depression; AnxietyLast Updated:January 10, 2020Unknown status
Condition(s):Mild Cognitive Impairment; Dementia; Alzheimer’s Type (Etiology)Last Updated:February 29, 2024Enrolling by invitation
Condition(s):Hearing Loss, Sensorineural; Bilateral Vestibulopathy; Alzheimer Disease; Mild Cognitive ImpairmentLast Updated:May 12, 2020Unknown status
Condition(s):HealthyLast Updated:July 6, 2016Unknown status
Condition(s):Parkinson’s DiseaseLast Updated:June 19, 2019Completed
Condition(s):Alzheimer’s Disease; Safety; Tolerability; Blood Concentration; Healthy VolunteersLast Updated:April 6, 2012Completed
Condition(s):DementiaLast Updated:January 30, 2024Completed
Condition(s):Neurodegenerative Diseases; Cognitive Decline; Parkinson Disease Dementia; Alzheimer Disease; Multiple SclerosisLast Updated:March 8, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.